CN Patent

CN110368360A — 具有增加的注射速度的阿立哌唑制剂

Assigned to Alkermes Pharma Ireland Ltd · Expires 2019-10-25 · 7y expired

What this patent protects

本发明涉及具有增加的注射速度的阿立哌唑制剂，包含式(I)化合物的药物组合物，其可用于使用快速注射速率肌内递送抗精神病药。

USPTO Abstract

本发明涉及具有增加的注射速度的阿立哌唑制剂，包含式(I)化合物的药物组合物，其可用于使用快速注射速率肌内递送抗精神病药。

Drugs covered by this patent

Patent Metadata

Patent number
CN110368360A
Jurisdiction
CN
Classification
—
Expires
2019-10-25
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.